Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
17.43
+0.36 (2.08%)
At close: Oct 21, 2025, 4:00 PM EDT
17.50
+0.07 (0.40%)
After-hours: Oct 21, 2025, 5:53 PM EDT
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $229.25 million as of October 21, 2025. Its market cap has increased by 2,239.24% in one year.
Market Cap
229.25M
Enterprise Value
125.61M
1-Year Change
2,239.24%
Ranking
Category
Stock Price
$17.43
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $229.25M, an increase of 564.48%. That is a compound annual growth rate of 20.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 224.60M | 190.93% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
| Nov 13, 2015 | 34.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.95B |
| Johnson & Johnson | 463.85B |
| AbbVie | 408.32B |
| UnitedHealth Group | 332.04B |
| AstraZeneca | 261.56B |
| Novartis AG | 254.74B |
| Novo Nordisk | 249.65B |
| Abbott Laboratories | 223.16B |